Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that ...
The 340B Drug Pricing Program must be reformed to better patient health and disincentivize institutional profit-seeking ...
Hospital and pharma groups have sharpened their spears for the rematch on 340B rebates. | The administration's second stab ...
The AHA responds to the Health Resources and Services Administration’s (HRSA) Request for Information regarding a potential 340B Rebate Model Pilot Program.
The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program ...
AHA urges HRSA to axe 340B model that would cost hospitals over $1 billion annually and increase administrative burdens.
Bipartisan agreement. Lower costs for patients. Saving money for taxpayers. While it may be hard to believe, there is one issue in Washington that meets the above criteria: fixing the 340B program.
The 340B Drug Pricing Program cuts prescription drug costs for safety-net hospitals, which often invest the savings in patient care.
Wadena, Staples and Perham healthcare executives say drug discounts are essential to funding emergency care, clinics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results